<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03633539</url>
  </required_header>
  <id_info>
    <org_study_id>RJ-mSILSC-2018</org_study_id>
    <nct_id>NCT03633539</nct_id>
  </id_info>
  <brief_title>Single-incision Versus Conventional Laparoscopic Surgery for Colorectal Cancer</brief_title>
  <acronym>mSILSC</acronym>
  <official_title>Multi-center Prospective Randomized Controlled Study of the Single-incision Laparoscopic Surgery Versus Conventional Laparoscopic Surgery for Colorectal Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ruijin Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Changhai Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fudan University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>RenJi Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Ruijin Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is designed to evaluate the short-term and long-term results after single incision
      laparoscopic surgery for colorectal cancer（SILSC） compared with conventional laparoscopic
      surgery for colorectal cancer（CLSC）.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In order to improve cosmetic effect and reduce postoperative pain, single-incision
      laparoscopic surgery (SILS) is attracting increasing attention. SILS is considered to be the
      next major advance in the progress of minimally invasive surgical approaches to colorectal
      disease that is more feasible in generalized use. In most previous studies, SILS for
      colorectal cancer was feasible and short-term safe compared to conventional laparoscopic
      surgery (CLS) . However, there is still controversy over its potential better cosmetic effect
      and less postoperative pain. Moreover, the long-term oncologic outcomes are still
      inconclusive as only a few studies showed long-term survival data. Up to now, most studies
      were limited to their retrospective nature and small samples. So more studies, especially
      large-scale, randomized controlled trials are needed to establish the best indications for
      SILS for colorectal cancer.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 2020</start_date>
  <completion_date type="Anticipated">December 2025</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative complications</measure>
    <time_frame>30 days after surgery</time_frame>
    <description>Postoperative complications rate 30 days after surgery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Operative time</measure>
    <time_frame>intraoperative</time_frame>
    <description>Operative time（minutes）</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intraoperative blood loss</measure>
    <time_frame>intraoperative</time_frame>
    <description>Estimated blood loss（milliliters，ml）</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incision length</measure>
    <time_frame>intraoperative</time_frame>
    <description>Incision length（centimeters，cm）</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lymph node detection</measure>
    <time_frame>14 days after surgery</time_frame>
    <description>Lymph nodes harvested（numbers）</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incisal margin</measure>
    <time_frame>14 days after surgery</time_frame>
    <description>Length of proximal and distal margin （centimeters，cm）</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tumor size</measure>
    <time_frame>14 days after surgery</time_frame>
    <description>The diameter of tumors（centimeters，cm）</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of stay</measure>
    <time_frame>1-14 days after surgery</time_frame>
    <description>Duration of hospital stay（days after surgery）</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative recovery course</measure>
    <time_frame>1-14 days after surgery</time_frame>
    <description>Time to first ambulation, flatus, liquid diet and soft diet （hours after surgery）</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain score</measure>
    <time_frame>1-3 days after surgery</time_frame>
    <description>Postoperative pain is recorded using the visual analog scale (VAS) pain score （0-10 points）tool on postoperative day 1, 2, 3 and the day of discharge</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>3-year disease free survival rate</measure>
    <time_frame>36 months after surgery</time_frame>
    <description>3-year disease free survival rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>5-year overall survival rate</measure>
    <time_frame>60 months after surgery</time_frame>
    <description>5-year overall survival rate</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">360</enrollment>
  <condition>Colorectal Cancer</condition>
  <condition>Colonic Neoplasms</condition>
  <condition>Rectal Neoplasms</condition>
  <condition>Colon Disease</condition>
  <condition>Colon Cancer</condition>
  <condition>Rectal Cancer</condition>
  <condition>Rectal Diseases</condition>
  <arm_group>
    <arm_group_label>Conventional Laparoscopic Surgery</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients with colorectal cancer undergo conventional laparoscopic surgery（multi-ports）.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Single-incision Laparoscopic Surgery</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients with colorectal cancer undergo single-incision laparoscopic surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Single-incision Laparoscopic Surgery</intervention_name>
    <description>Patients undergo single-incision laparoscopic surgery. In this group，the surgery is performed through a transumbilical port. The surgeon will adjust surgical position to expose the operative field with the help of gravity. Besides，hand over hand cross and parallel techniques are needed to achieve the SILS. All the other operative procedures are the same as conventional laparoscopic surgery.</description>
    <arm_group_label>Single-incision Laparoscopic Surgery</arm_group_label>
    <other_name>SILSC</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Conventional Laparoscopic Surgery</intervention_name>
    <description>Patients undergo conventional laparoscopic surgery. In this group，the surgery is performed through 3-5 ports according to the surgeons habits and specific conditions.</description>
    <arm_group_label>Conventional Laparoscopic Surgery</arm_group_label>
    <other_name>CLSC</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Inclusion Criteria:

          -  18 years &lt; age ≤85 years

          -  Tumor located in colon and high rectum ( the lower border of the tumor is above the
             peritoneal reflection)

          -  Pathological colorectal carcinoma

          -  Clinically diagnosed cT1-4aN0-2 M0 lesions according to the 8th Edition of AJCC Cancer
             Staging Manual

          -  Tumor size of 5 cm or less

          -  ECOG score is 0-1

          -  ASA score is Ⅰ-Ⅲ

          -  Informed consent

        Exclusion Criteria:

          -  Body mass index (BMI) &gt;35 kg/m2

          -  The lower border of the tumor is located distal to the peritoneal reflection

          -  Pregnant woman or lactating woman

          -  Severe mental disease

          -  Previous abdominal surgery（except appendectomy and cholecystotomy）

          -  Emergency operation due to complication (bleeding, perforation or obstruction) caused
             by colorectal cancer

          -  Requirement of simultaneous surgery for other disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kun Liu, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Ruijin Hospitla North</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ren Zhao, MD</last_name>
    <phone>18917762018</phone>
    <email>zhaorensurgeon@aliyun.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Ruijin Hospital North</name>
      <address>
        <city>Shanghai</city>
        <zip>201801</zip>
        <country>China</country>
      </address>
    </facility>
    <contact>
      <last_name>Kun Liu, MD</last_name>
      <phone>18121263082</phone>
      <email>lookiere@126.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <results_reference>
    <citation>Song Z, Li Y, Liu K, Jiang Y, Shi Y, Ji X, Zhang T, Wu H, Shi Y, Zhao R. Clinical and oncologic outcomes of single-incision laparoscopic surgery for right colon cancer: a propensity score matching analysis. Surg Endosc. 2019 Apr;33(4):1117-1123. doi: 10.1007/s00464-018-6370-2. Epub 2018 Jul 24.</citation>
    <PMID>30043168</PMID>
  </results_reference>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>August 14, 2018</study_first_submitted>
  <study_first_submitted_qc>August 14, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 16, 2018</study_first_posted>
  <last_update_submitted>February 12, 2020</last_update_submitted>
  <last_update_submitted_qc>February 12, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ruijin Hospital</investigator_affiliation>
    <investigator_full_name>Zhao Ren</investigator_full_name>
    <investigator_title>Chief Physicion</investigator_title>
  </responsible_party>
  <keyword>SILS</keyword>
  <keyword>colorectal cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
    <mesh_term>Rectal Neoplasms</mesh_term>
    <mesh_term>Colonic Neoplasms</mesh_term>
    <mesh_term>Rectal Diseases</mesh_term>
    <mesh_term>Colonic Diseases</mesh_term>
    <mesh_term>Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

